objectiveFIELD®

The first-ever objectiveField Analyzer (OFA®)

objectiveFIELD® is the first and only truly objective perimeter FDA 510(k) cleared to assess visual field abnormalities.

Finally! Patients no longer have to press a button.

Overview

objectiveFIELD® utilizes a novel method called Multifocal Pupillographic Objective Perimetry (mfPOP), which is analogous to multifocal ERG/VEP, but without electrodes.

The exam is bilateral, and takes approximately 90 seconds or 7 minutes, for both eyes, depending on which test protocol is selected.

Both eyes are individually tested, at the same time (a dichoptic presentation).

  • No patient response required
  • Eye patching is not required
  • No variability between OD & OS exams
    (SAP is two exams at different points in time)
Clinical Applications

objectiveFIELD® is an FDA (510k) Cleared device for the assessment of visual field abnormalities

objectiveFIELD is not FDA cleared for the specific diagnosis of any condition.

Clinical Benefits

Completely objective, no button to press

Bilateral exam, no eye patch needed

Good correlation of glaucomatous RNFL loss with visual field loss

Regulatory

FDA 510(k) Cleared | CPT Code 92083

Health Canada Licensed

Pharmaceuticals and Medical Devices Agency (Japan)

CE Mark pending

What Visual Field Test Protocols Are Available?

OFA includes test protocols for 30 & 24 (together), 15 and 10 degrees per-eye. The OFA 30 test protocol delineates a 24 degree field at the same time, in the same report, as no extra time is required to test a 30 degree visual field vs 24 degrees.

What Does objectiveFIELD® Measure?

Using a combination of innovative hardware and software, each eye’s field of vision is optically separated, and the patient’s view is fused (cyclopean view).

Novel stimuli are presented to each eye individually, interleaved, with non-overlapping timing, every ¼ second.
Pupillary responses are recorded using video cameras under infra-red light and analyzed using sophisticated pupil tracking (not gaze tracking).

Sensitivity is measured objectively from the amplitude of the pupillary response (relative change in pupil size) and converted to the familiar decibel scale.

Latency (time-to-peak constriction) of the pupillary responses are also measured in milliseconds, which is new information not available in any other perimeter.

The result is four visual fields per eye.

  1. OD / OS sensitivity, direct
  2. OD / OS sensitivity, consensual
  3. OD / OS latency, direct
  4. OD / OS latency consensual

Sophisticated analytics combine these data into two reports (sensitivity and latency) for both eyes, which follow a familiar reporting structure with familiar visual field maps and indices, so there is no learning curve to interpret reports.

Reporting

OFA reports are presented in a classic format for both sensitivity and delay, with familiar grey-scale and numeric maps, as well as a table of global VF indices including MD, PSD, SF, CPSD etc.

Scientific and Clinical Publications

Frequently Asked Questions
How does objectiveFIELD work?
The objectiveFIELD® Analyzer (OFA®) uses multifocal pupillographic objective perimetry (mfPOP) to measure the direct and consensual pupillary responses to spatially resolved stimuli. mfPOP assesses both sensitivity and response time at each of the visual field locations in both eyes simultaneously.
How long does a test take?
The 30-degree and 15-degree tests are both approximately 7 mins, for both eyes, simultaneously.
How does objectiveFIELD compare to standard automated perimetry?
objectiveFIELD® (OFA®) is 100% objective and utilizes a dichoptic presentation stimulus. It is easy on patients and technicians because there is no button to push and both eyes are tested at the same time.

Responses are measured objectively using a patented “Clustered Volley”, multifocal pupillographic objective perimetry method (mfPOP). OFA® stimuli covers more than 99% of the 30-2 retinal area, while SAP Goldman III stimuli only samples approximately 0.5% of the 30-2 area with the assumption that the remaining 99.5% of the non-sampled central area is well represented by the small stimuli.

Are there any disposables used?
No. There are no disposable parts. Similar to many diagnostic devices, the forehead rest can be sanitized in between patients using alcohol wipes.
Can the device accommodate smaller faces?
The human interface design is designed for a wide range of human morphology.
Is refractive correction required?
OFA® stimuli are designed to be less susceptible to refractive errors and lens brunescence than SAP. Trial lenses are provided in 3 diopter steps for larger refractive errors.

Product Specifications

Fundamental Method Multifocal pupillographic objective perimetry (mfPOP)
Intended Clinical Purpose and Use Visual field examination to measure visual field abnormalities
Visual System Stimulus Patented clustered volley, sparse, multifocal stimulus
Visual Function Assessment Regression-based multifocal analysis
Visual Field Defect Assessment Population sample normal database comparison
 Test Options 30°, 24°, 15°, 10° tests
Trial Lenses +3D, -3D, +6D, -6D, +9D, -9D
 Background Brightness 10 cd/m2
Regulatory FDA 510(k) Cleared K063310

Intended Purpose of Device & Indications for Use

This device is not intended to diagnose any disease. Use of the device in such a manner may result in misdiagnosis of serious pathologies. It is solely the physician’s or operator’s responsibility to interpret the test results.

The intended use of the device is to aid in the measurement of visual field abnormalities.

The device is intended for use by healthcare professionals or paraprofessionals in either a professional healthcare environment or other places where patients are present.

objectiveFIELD® should not be used to examine the following category of patients, this category may include, but not be limited to: patients with irregular shaped and stationary pupils; patients with Horner’s syndrome or other disorders affecting pupil response; patients with unusually small pupils or patients treated by drugs that would affect the pupil reactivity.

What Konan Medical Customers Say

The service delivered by Konan is some of the best I have experienced in the ophthalmic field.

George O. Rosenwasser, MD
Central Pennsylvania Eye Institute – Medical Director, Gift of Life Donor Program Eye Bank

Simply an indispensable technology for Ophthalmology and Optometry, from Konan Medical, the “Apple” of ophthalmic device companies.

Paul Karpecki, OD, FAAO
Clinical Director, Kentucky Eye Institute
Chief Clinical Editor, Review of Optometry
Associate Professor, Kentucky College of Optometry

Thank you to Konan for transforming eye disease detection and patient care!

Glen R. Owen, OD, FAAO
Edmonds Eyecare Associates, WA

My offices have had Konan endothelial microscopes for about 3 years. Not only does Konan specular microscopy give great clinical information it also paid for itself well within the first year.

Kerry Gelb, OD
Contact Lens and Vision